Why Amarin Rose as Much as 7.9% Today
Amarin (NASDAQ: AMRN) spiked nearly 8% on Tuesday before falling to earth and landing essentially flat over Monday's close. Amarin announced that the regulatory approval process for Vascepa has started in China and Hong Kong. On the mainland, the Chinese National Medical Products Administration has accepted a new drug application for the medicine.